Other Cancers Initial Safety Results of Elranatamab in R/R MM: Phase 2 MagnetisMM-3 Trial May 24, 2023
Other Cancers The Efficacy of Dabrafenib Plus Trametinib in BRAFV600E-Mutated Rare Cancers Assessed May 23, 2023
Other Cancers Cilta-Cel in Lenalidomide-Refractory MM: Study Updates and Biological Analyses May 23, 2023
Other Cancers Elotuzumab-Based Treatment for Refractory Multiple Myeloma in First Relapse Analyzed May 23, 2023
Gynecologic Cancer,Other Cancers Olaparib Plus Bevacizumab Efficacy Predicted in First-Line Ovarian Cancer Using HR Gene Mutations May 22, 2023
Gastrointestinal Cancer,Other Cancers 177Lu-DOTA0-Tyr3-Octreotate vs. Octreotide LAR in Somatostatin Receptor Positive Tumours May 22, 2023
